Carlos Lopez-Espina
Chief Technology Officer
Carlos Lopez-Espina is an innovator and multidisciplinary problem solver focused on biotechnology, clinical research and product development.
Carlos led the building of the Prenosis platform, the world’s most comprehensive system for understanding acute immune response. Previously he worked in medical devices and diagnostics in a wide range of disciplines aimed at converting ideas into solutions, including several successful FDA clearances and market launches of IVD devices. Carlos studied aeronautical engineering at the Polytechnic University of Madrid and earned his M.S. in Mechanical Engineering from the University of Illinois at Chicago.
Carlos Lopez-Espina in the News
Check out the latest publications from our Chief Technology Officer.
Prenosis Announces $20M BARDA Contract and $20M Series A Financing Round, Advancing Mission to Deliver Integrated Diagnostics and Therapeutics
Read More →
Multivariate protein landscape of host response in hospitalised patients with suspected infection in the emergency department
Read More →
Biomarker-based Clustering to Identify Distinct Host Response Signatures in Hospitalized Patients With Suspected Infection
Read More →
Advancing Equity in Acute Care
Read More →
Prenosis Inc. Appoints Leadership Team for Commercialization In Hospitals
Read More →